Joshina Kapoor (India) jkapoor2@ITS.JNJ.com +919820711080
Jessica Freifeld (Global) email@example.com +1 917-520-1198
Awardees Announced for the DR-TB Lifeline QuickFire Challenge
- Two of the five awardees – who will receive both $50,000 in grant funding and mentorship from J&J experts – are Indian NGOs renowned for their work in TB Care and Management – Doctors For You and ZMQ Global.
- In leveraging telemedicine and patient-centric mobile solutions, the winners aim to ensure continued access to critical DR-TB care and management to the patients.
September 16, 2020 —Johnson & Johnson’s Global Public Health team, together with Johnson & Johnson Innovation – JLABS, announced today that DOCTORS FOR YOU, ZMQ Global, De La Salle Medical and Health Sciences Institute, Keheala and CO TBpeopleUkraine, have been selected as the awardees in the Drug Resistant-TB Lifeline QuickFire Challenge. The Challenge was designed with the aim to ensure continuity of care for those diagnosed with and undergoing treatment for DR-TB in the wake of the COVID 19 pandemic.
To advance their research, the awardees will receive a combined total of $250,000 in grant funding and will also have the opportunity to engage with experts at the Johnson & Johnson Family of Companies.
DOCTORS FOR YOU
An implementable & sustainable solution to continue provide critical DR-TB care services during ongoing COVID-19 using Telemedicine & NIKSHAY DR-TB services delivery boy to strengthen National Tuberculosis Elimination Program (NTEP) of Govt. of India.
PACT – Patient’s Active Compliance and Treatment toolkit is a patient-centric mobile solution which has 3 main features – Adherence reporting using VOT (asynchronous video observed treatment reporting) & self-tracking of treatment; Health System Connect for Consultation & Emergency Care (synchronous video observation therapy mode); and built-in digital tools for Behavior Change Communication to motivate DR TB patients and build their capacities.
De La Salle Medical and Health Sciences Institute
Asynchronized VOT utilizing SureAdhere software, a simple application that can be downloaded to any smartphone that records patients dosing for healthcare workers to view for compliance.
Keheala is a digital adherence technology, which uses behavioral economics and basic feature phones to ‘nudge’ and support patients through their treatment process.
By scaling-up OneImpact mobile application as an efficient tool to enhance TB-patient outreach, monitor barriers and rights violations, TBpeopleUkraine empowers the TB community to respond to challenges encountered during TB-treatment in a timely manner in order to support adherence, reduce the risks of separation from therapy and implement patient-centered approach in treatment and care model.
The QuickFire Challenges are managed by Johnson & Johnson Innovation, JLABS, with the aim to address today’s greatest health care challenges.
About Johnson & Johnson’s Global Public Health
Charting a bold new, self-sustainable approach, Johnson & Johnson has established the first fully dedicated organization within a healthcare company focused on combining innovative R&D, novel access programs & approaches, in-country operations, advocacy and the power of multi-sectoral partnerships to ensure that treatments and technologies are available, affordable and accessible for the world’s most under-served populations. Harnessing the extensive resources and expertise from across Johnson & Johnson, its Global Public Health team is placing an unparalleled focus on accelerating the pace of innovation needed – from discovery to delivery – to make TB and HIV history, eliminate intestinal worms, address mental health and wrestle other public health challenges.
About Johnson & Johnson Innovation
Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation – JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.
About Johnson & Johnson Innovation – JLABS
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jnj.com/global-public-health and follow us @JNJGlobalHealth.
Read more from the Health Issues India press office here.